Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A Ramirez

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Ochsner Journal|December 13, 2017
From the Guest Editor: The Rapidly Changing Field of Cancer TreatmentRobert A Ramirez
Current Treatment Options in Oncology|January 16, 2026
Management of Peptide Receptor Radionuclide Therapy Toxicities in Neuroendocrine Neoplasm PatientsChirayu Mohindroo, Robert A Ramirez
Lancet (London, England)|June 8, 2024
The developing role of theranostics in NETsRobert A Ramirez, Cathy Eng
Ochsner Journal|December 13, 2017
The Role of Checkpoint Inhibition in Non-Small Cell Lung CancerJonathan Lu, Robert A Ramirez
Ochsner Journal|December 13, 2017
Molecular Targets in Non-Small Cell Lung CancerRyan Griffin, Robert A Ramirez
Lung|June 27, 2015
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) and the Role of Somatostatin analogs: A Case SeriesAman Chauhan, Robert A Ramirez
The Journal of Community and Supportive Oncology|February 10, 2016
Lung cancer in HIV-infected patients and the role of targeted therapyMarco Ruiz, Robert A Ramirez
Ochsner Journal|December 13, 2017
Leptomeningeal Disease and the Evolving Role of Molecular Targeted Therapy and ImmunotherapyKatharine Hall Thomas, Robert A Ramirez
Translational Lung Cancer Research|May 22, 2018
Quality of life for non-small cell lung cancer patients in the age of immunotherapyRobert A Ramirez, Jonathan Lu, Katharine E H Thomas
Current Problems in Cancer|January 28, 2024
Current and emerging strategies for the management of advanced/metastatic lung neuroendocrine tumorsMegan Rutherford, Margaret Wheless, Katharine Thomas, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Ochsner Journal|December 13, 2017
From the Guest Editor: The Rapidly Changing Field of Cancer TreatmentRobert A Ramirez
Current Treatment Options in Oncology|January 16, 2026
Management of Peptide Receptor Radionuclide Therapy Toxicities in Neuroendocrine Neoplasm PatientsChirayu Mohindroo, Robert A Ramirez
Lancet (London, England)|June 8, 2024
The developing role of theranostics in NETsRobert A Ramirez, Cathy Eng
Ochsner Journal|December 13, 2017
The Role of Checkpoint Inhibition in Non-Small Cell Lung CancerJonathan Lu, Robert A Ramirez
Ochsner Journal|December 13, 2017
Molecular Targets in Non-Small Cell Lung CancerRyan Griffin, Robert A Ramirez
Lung|June 27, 2015
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) and the Role of Somatostatin analogs: A Case SeriesAman Chauhan, Robert A Ramirez
The Journal of Community and Supportive Oncology|February 10, 2016
Lung cancer in HIV-infected patients and the role of targeted therapyMarco Ruiz, Robert A Ramirez
Ochsner Journal|December 13, 2017
Leptomeningeal Disease and the Evolving Role of Molecular Targeted Therapy and ImmunotherapyKatharine Hall Thomas, Robert A Ramirez
Translational Lung Cancer Research|May 22, 2018
Quality of life for non-small cell lung cancer patients in the age of immunotherapyRobert A Ramirez, Jonathan Lu, Katharine E H Thomas
Current Problems in Cancer|January 28, 2024
Current and emerging strategies for the management of advanced/metastatic lung neuroendocrine tumorsMegan Rutherford, Margaret Wheless, Katharine Thomas, et al.
Pageof 6